October 15, 2019
Ligand Appoints Pharmaceutical Executive Sarah Boyce to its Board of Directors
SAN DIEGO–(BUSINESS WIRE)–Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) (“Ligand” or “the Company”) announces the appointment of Sarah Boyce to the Company’s…